NIH-funded research R21 grant

Creating a baboon model to study uterine fibroids

Official title: Developing a baboon model for uterine fibroids

Funded at Henry Ford Health + Michigan State University Health Sciences · NIH-10887922 · Data updated 2026-11-12

This study is working with baboons to learn more about uterine fibroids, which are non-cancerous growths that many women experience, so that we can find better ways to treat them.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionHenry Ford Health + Michigan State University Health Sciences
NIH-funded
Lab location1 site (East Lansing, United States)
Project startAugust 1, 2024
Project endJuly 31, 2026
Funding year2024
Award (this year)$235,500
NIH project number1R21HD112649-01A1
Project IDNIH-10887922 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are women experiencing symptoms related to uterine fibroids, particularly those who may require surgical intervention.

Less likely to help

Patients who do not have uterine fibroids or are not experiencing related symptoms may not benefit from this research.

What this research studies

This research aims to develop a reliable baboon model to better understand uterine fibroids, which are common benign tumors affecting many women. By using baboons, researchers hope to gain insights into the biological mechanisms behind fibroid development, which are currently poorly understood. The study will involve two phases to establish this model, allowing for more effective investigation of fibroids compared to existing animal models. This could lead to improved treatment options for women suffering from fibroids.

Why it matters

Potential benefit: If successful, this research could lead to better understanding and treatment options for women with uterine fibroids.

How similar studies have gone: While there have been various animal models for studying fibroids, the use of a baboon model is relatively novel and has not been extensively tested in this context.

Where this research is happening

  • Henry Ford Health + Michigan State University Health Sciences
    East Lansing, United States
    Active

Researchers

  • Principal investigator: Teixeira, Jose M. — Henry Ford Health + Michigan State University Health Sciences
  • Study coordinator: Teixeira, Jose M.

Related research

Other NIH-funded projects on the same topics.

  • Keloid recurrence study using multi-omics in diverse patients

    A research effort will look at why keloids come back after surgery, especially in African American patients, using comprehensive molecular data from patient samples.

    NIH research Henry Ford Health + Michigan State University Health Sciences · East Lansing, United States · NIH-11641647

  • A national program to build a precise, personalized health data platform for all of us participants

    This grant supports expanding and improving a national health data platform to help tailor care to each person using their genetic, health, and lifestyle information.

    NIH research Henry Ford Health + Michigan State University Health Sciences · East Lansing, United States · NIH-11579106

  • Computational modeling of female hormone balance and drug responses

    A new computational model uses patient-like data to predict how metabolic drugs will work in women across their hormonal cycles and different reproductive stages.

    NIH research Henry Ford Health + Michigan State University Health Sciences · East Lansing, United States · NIH-11562918

  • Anti-CD38 immunotherapy for severe hidradenitis suppurativa

    A new treatment using anti-CD38 therapy is being tested for people with severe hidradenitis suppurativa who have not responded to prior therapies.

    NIH research Henry Ford Health + Michigan State University Health Sciences · East Lansing, United States · NIH-11526578

  • Vitamin D, gut bacteria and dementia risk in older adults with HIV

    This work will look at whether low vitamin D and changes in gut bacteria are linked to higher dementia risk in older adults living with chronic HIV and similar community members.

    NIH research Henry Ford Health + Michigan State University Health Sciences · East Lansing, United States · NIH-11517874

  • Screening new compounds to reverse gene signatures in IPF lungs

    A researcher hopes to find compounds that reverse harmful gene changes in the lungs of people with idiopathic pulmonary fibrosis (IPF).

    NIH research Henry Ford Health + Michigan State University Health Sciences · East Lansing, United States · NIH-11494256

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.